🇺🇸 FDA

Company profile · Sponsor

NeuroSense

NeuroSense Therapeutics

NRSN · NYSE pharma HERZLIYA, L3, USA
Pipeline
6
Drugs
0
Patents
2

Quick answer

NeuroSense (NRSN) is a pharma company. headquartered in HERZLIYA, L3, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker NRSN
Exchange NYSE
Company type pharma
Headquarters HERZLIYA, L3, USA
SEC CIK 0001875091

Pipeline (6)

Search pipeline →

  1. Fixed dose combination Ciprofloxacin/Celecoxib

    NeuroSense

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule completed

    1 trial

  2. PrimeC

    NeuroSense

    Alzheimer Disease

    phase 2 small molecule terminated

    1 trial

  3. PrimeC

    NeuroSense

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule completed

    1 trial

  4. Fixed dose combination Ciprofloxacin/Celecoxib

    NeuroSense

    ALS (Amyotrophic Lateral Sclerosis)

    phase 1 small molecule completed

    1 trial

  5. PrimeC 748 mg

    NeuroSense

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  6. PrimeC-ER 748 mg

    NeuroSense

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

Patents (2)

Search patents →

  1. US 12097185

    Compositions comprising ciprofloxacin and celecoxib

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10980780

    Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is NeuroSense?

NeuroSense (NRSN) is a pharma company. headquartered in HERZLIYA, L3, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does NeuroSense sponsor?

We track 6 ClinicalTrials.gov-linked programs for NeuroSense, including Fixed dose combination Ciprofloxacin/Celecoxib and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does NeuroSense company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.